BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6644331)

  • 1. Leukocyte interferon (IFN alpha) in patients with epithelial ovarian carcinoma.
    Freedman RS; Gutterman JU; Wharton JT; Rutledge FN
    J Biol Response Mod; 1983; 2(2):133-8. PubMed ID: 6644331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Berek JS; Hacker NF; Lichtenstein A; Jung T; Spina C; Knox RM; Brady J; Greene T; Ettinger LM; Lagasse LD
    Cancer Res; 1985 Sep; 45(9):4447-53. PubMed ID: 4028027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant leukocyte alpha interferon in advanced ovarian carcinoma.
    Niloff JM; Knapp RC; Jones G; Schaetzl EM; Bast RC
    Cancer Treat Rep; 1985; 69(7-8):895-6. PubMed ID: 4016797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal recombinant alpha 2-interferon for 'salvage' immunotherapy in persistent epithelial ovarian cancer.
    Berek JS; Hacker NF; Lichtenstein A; Jung T; Spina C; Knox RM; Brady J; Greene T; Ettinger LM; Lagasse LD
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():23-32. PubMed ID: 3833327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of interferon-alpha on macrophage activation in patients with ovarian carcinoma and cervical dysplasia.
    Fuith LC; Fuchs D; Hausen A; Hetzel H; Reibnegger G; Werner ER; Wachter H
    J Clin Lab Immunol; 1989 Jun; 29(2):65-9. PubMed ID: 2632803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal alpha interferon for ovarian cancer: a case report.
    Carney-Gersten P; Moore MD; Giuffre M
    Oncol Nurs Forum; 1990; 17(3):403-7. PubMed ID: 2342974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of alpha (human leukocyte) interferon administered daily in adenocarcinoma of the colon/rectum.
    Figlin RA; Callaghan M; Sarna G
    Cancer Treat Rep; 1983 May; 67(5):493-4. PubMed ID: 6850664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal interferon-alpha in residual ovarian carcinoma: a phase II gynecologic oncology group study.
    Berek JS; Markman M; Stonebraker B; Lentz SS; Adelson MD; DeGeest K; Moore D
    Gynecol Oncol; 1999 Oct; 75(1):10-4. PubMed ID: 10502418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and hematologic toxicity of salvage chemotherapy following stem cell-supported high-dose chemotherapy in women with recurrent ovarian cancer.
    Cook S; Penson R; Duska L; Nikrui N; Goodman A; Fuller A; Seiden M
    Gynecol Oncol; 2000 Apr; 77(1):48-54. PubMed ID: 10739690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effects of human fibroblast interferon in advanced gynecological cancers].
    Kanazawa K; Honma S; Yuzawa H; Takeuchi S
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1276-83. PubMed ID: 6732254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of recombinant interferon alpha-2 (Sch 30500) in advanced gynecological cancers].
    Kasamatsu T; Ohmi K; Takeuchi S; Takamizawa H; Matsuzawa M; Kawana T; Ueda K; Kubo H; Tsumuji Y; Kawashima Y
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1656-60. PubMed ID: 3896157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multidisciplinary treatment of recurrent epithelial ovarian carcinoma and prognostic analysis].
    Huang X; Cai SM; Tang J; Li ZT; Zang RY
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):602-5. PubMed ID: 15498187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer.
    Wolf JK; Bodurka DC; Gano JB; Deavers M; Ramondetta L; Ramirez PT; Levenback C; Gershenson DM
    Gynecol Oncol; 2004 Aug; 94(2):442-8. PubMed ID: 15297186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
    Elsässer-Beile U; Kölble N; Grussenmeyer T; Wetterauer U; Schultze-Seemann W
    Anticancer Res; 1998; 18(3B):1883-90. PubMed ID: 9677439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC).
    Alici S; Saip P; Eralp Y; Aydiner A; Topuz E
    Am J Clin Oncol; 2003 Aug; 26(4):358-62. PubMed ID: 12902885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
    Hudes GR; Lipsitz S; Grem J; Morrisey M; Weiner L; Kugler JW; Benson A
    Cancer; 1999 Jan; 85(2):290-4. PubMed ID: 10023694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.